Holen Sie sich die Stockscreener-App
2.32
3.57%
0.08
Handel nachbörslich:
2.31
-0.010
-0.43%
Schlusskurs vom Vortag:
$2.24
Offen:
$2.32
24-Stunden-Volumen:
9,333
Relative Volume:
0.09
Marktkapitalisierung:
$29.50M
Einnahmen:
$2.47M
Nettoeinkommen (Verlust:
$-13.87M
KGV:
-1.9016
EPS:
-1.22
Netto-Cashflow:
$-12.42M
1W Leistung:
+5.45%
1M Leistung:
-11.45%
6M Leistung:
-5.31%
1J Leistung:
-50.28%
1-Tages-Spanne:
$2.26
$2.32
1-Wochen-Bereich:
$2.09
$2.4426
52-Wochen-Spanne:
$1.31
$4.99
Collplant Biotechnologies Ltd Stock (CLGN) Company Profile
Firmenname
Collplant Biotechnologies Ltd
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie CLGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLGN
Collplant Biotechnologies Ltd
|
2.32 | 28.48M | 2.47M | -13.87M | -12.42M | -1.22 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Collplant Biotechnologies Ltd Stock (CLGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-02-17 | Eingeleitet | Alliance Global Partners | Buy |
Collplant Biotechnologies Ltd Aktie (CLGN) Neueste Nachrichten
Strategies to average down on CollPlant Biotechnologies Ltd.Profit Target & Stepwise Entry/Exit Trade Alerts - newser.com
What is the fair value of CollPlant Biotechnologies Ltd. stock nowFed Meeting & Safe Capital Growth Stock Tips - newser.com
Will CollPlant Biotechnologies Ltd. stock outperform Nasdaq indexWeekly Stock Report & Consistent Profit Trade Alerts - newser.com
Published on: 2025-10-13 10:29:10 - newser.com
Is CollPlant Biotechnologies Ltd. stock dividend yield sustainableJuly 2025 Decliners & High Conviction Buy Zone Picks - newser.com
How CollPlant Biotechnologies Ltd. stock benefits from tech adoptionJuly 2025 Volume & Reliable Price Breakout Alerts - newser.com
What drives CollPlant Biotechnologies Ltd CPT stock priceEnergy Sector Updates & Rapid Capital Gain - earlytimes.in
Visualizing CollPlant Biotechnologies Ltd. stock with heatmapsEarnings Growth Summary & Short-Term High Return Strategies - newser.com
CollPlant Biotechnologies Ltd. stock prediction for this weekJuly 2025 News Drivers & Accurate Entry and Exit Point Alerts - newser.com
Analyzing CollPlant Biotechnologies Ltd. with multi timeframe chartsQuarterly Growth Report & Capital Efficient Trade Techniques - newser.com
CollPlant Biotechnologies (NASDAQ:CLGN) Trading Down 7.6% – What’s Next? - Defense World
CollPlant Biotechnologies Ltd CPT Stock Analysis and ForecastMerger & Acquisition Updates & Market Trend Real-Time Reports - earlytimes.in
Historical volatility pattern of CollPlant Biotechnologies Ltd. visualized2025 Trading Recap & Fast Exit and Entry Strategy Plans - newser.com
Why CollPlant Biotechnologies Ltd. stock is trending among retail traders2025 Big Picture & Verified Entry Point Signals - newser.com
Quantitative breakdown of CollPlant Biotechnologies Ltd. recent moveTrend Reversal & Safe Entry Momentum Tips - newser.com
Multi factor analysis applied to CollPlant Biotechnologies Ltd.Earnings Summary Report & Entry Point Confirmation Alerts - newser.com
Tools to assess CollPlant Biotechnologies Ltd.’s risk profileWeekly Stock Summary & Community Driven Trade Alerts - newser.com
How to manage a losing position in CollPlant Biotechnologies Ltd.Weekly Gains Summary & Fast Exit and Entry Trade Guides - newser.com
One CollPlant Biotechnologies Insider Raised Their Stake In The Previous Year - Yahoo Finance
Comparing CollPlant Biotechnologies Ltd. in custom built stock radarsWeekly Gains Report & Capital Efficiency Focused Strategies - newser.com
Using data filters to optimize entry into CollPlant Biotechnologies Ltd.Portfolio Performance Summary & Community Trade Idea Sharing - newser.com
Collplant stock plunges after advancing dermal filler to clinical trials By Investing.com - Investing.com Nigeria
Collplant stock plunges after advancing dermal filler to clinical trials - Investing.com
CollPlant advances photocurable dermal filler to clinical trials By Investing.com - Investing.com Australia
CollPlant advances photocurable dermal filler to clinical trials - Investing.com India
CollPlant Biotechnologies Announces Positive Results from non-clinical Studies of its Photocurable Regenerative Dermal and Soft Tissue Filler - MarketScreener
United States 3D Printed Organ Market Set to Transform - openPR.com
Finanzdaten der Collplant Biotechnologies Ltd-Aktie (CLGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):